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The NADPH-dependent dimeric flavoenzyme 4-hydroxyaceto-
phenone monooxygenase (HAPMO) catalyzes Baeyer-Villiger oxi-
dations of a wide range of ketones, thereby generating esters or
lactones. In the current work, we probed HAPMO-coenzyme com-
plexes present during the enzymecatalytic cyclewith the aim togain
mechanistic insight. Moreover, we investigated the structural role
of the nicotinamide coenzyme. For these studies, we used (i) wild
type HAPMO, (ii) the R339A variant, which is active but has a low
affinity toward NADPH, and (iii) the R440A variant, which is inac-
tive but has a high affinity toward NADPH. Electrospray ionization
mass spectrometry was used as the primary tool to directly observe
noncovalent protein-coenzyme complexes in real time. These ana-
lyzes showed for the first time that the nicotinamide coenzyme
remains bound to HAPMO during the entire catalytic cycle of the
NADPHoxidase reaction. Thismay also have implications for other
homologous Baeyer-Villiger monooxygenases. Together with the
observations that NADP only weakly interacts with oxidized
enzyme and that HAPMO is mainly in the reduced form during
catalysis, we concluded that NADP interacts tightly with the
reduced form of HAPMO. We also demonstrated that the associa-
tion with the coenzyme is crucial for enzyme stability. The interac-
tion with the coenzyme analog 3-aminopyridine adenine dinucle-
otide phosphate (AADP) strongly enhanced the thermal stability
of wild type HAPMO. This coenzyme-induced stabilization may
also be important for related enzymes.
The interaction of proteins with small molecules, such as ligands and
cofactors, often coincides with an increased stability of the protein due
to the coupling of binding with the unfolding equilibrium (1–4). Thus,
apart from their catalytic role, cofactors may also have a structural role.
The importance of cofactor binding for protein stability is revealed for
several flavoproteins (2). The common polymorphism 677TC3 T in
methylenetetrahydrofolate reductase causing the single point mutation
A222V reduces the affinity of the enzyme for the FAD cofactor, result-
ing in a lower thermal stability (5, 6). For the octameric protein vanillyl-
alcohol oxidase, it was demonstrated that cofactor binding influences
the quaternary architecture of the enzyme (7). The H61T mutant is
purified as apo-enzyme and mainly exists as a dimeric species. The
binding of FAD to the enzyme restores the octameric conformation (7,
8). Similarly, for lipoamide dehydrogenase, it was shown that FADbind-
ing increases the protein melting temperature from 35 to 80 °C (9).
Coenzymes such as NAD(P) and NAD(P)H can have, besides from
their function in electron transfer, also a structural role. Several liver and
pectoral muscle enzymes are substantially protected by NAD(P)
against heat and proteolysis by trypsin (10). Phosphite dehydrogenase is
stabilized by NAD (11), and DNA ligases becomemore compact upon
anchoring coenzyme NAD (12).
In the present work, we have studied the noncovalent interactions
between the oxidized or reduced nicotinamide coenzyme (NADP or
NADPH) and the flavoenzyme 4-hydroxyacetophenone monooxygen-
ase (HAPMO).4 HAPMO from Pseudomonas fluorescens ACB is a
Baeyer-Villiger monooxygenase (BVMO), which converts a wide range
of ketones into the corresponding esters or lactones (13). The enzyme is
also able to performenantioselective sulfoxidations (14). In recent years,
BVMOs have received increasing attention, representing a promising
alternative for chemical oxidations reactions allowing highly selective
oxygen insertion reactions (15, 16).
HAPMO is a so-called type I BVMO. These enzymes contain FAD as
a cofactor and use NADPH as a source for electrons, whereas Type II
BVMOs contain FMN and useNADH (17). Type I BVMOs contain two
Rossman folds, which are involved in the binding of theADPmoieties of
FAD and NADPH (18). Together with bacterial N-hydroxylating
monooxygenases and eukaryotic flavin-containing monooxygenases,
type I BVMOs form a newly identified superfamily of flavoprotein
monooxygenases (19), which is distinct from the family of flavoprotein
aromatic hydroxylases. Recently, the crystal structure of phenylacetone
monooxygenase from Thermobifida fusca was solved (20). This first
structure of a type I BVMO revealed a two-domain architecture and
highlighted the importance of an active site arginine, which seems crit-
ically involved in substrate oxygenation. Replacement of this conserved
arginine in HAPMO (R440A) does not impair NADPH binding but
results in complete enzyme inactivation (21). From site-directed
mutagenesis, it was also established that Arg-339 and Lys-439 are
involved in determining the coenzyme specificity of HAPMO. The
R339A mutant showed a largely decreased affinity for NADPH, as
judged from kinetic analysis and binding experiments. Saturation
mutagenesis of Lys-439 suggested that this residue is involved in the
binding of the 2-phosphate ofNADPHand allowed to change the coen-
zyme specificity of HAPMO in favor of NADH (21).
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Fig. 1 shows the proposedmechanism of action of BVMOs (22). After
flavin reduction by NADPH and reaction with oxygen, the generated
flavin C4a-peroxide attacks the carbonyl carbon of the substrate. After
product formation, water is released from the resulting hydroxyflavin,
regenerating the oxidized enzyme. For cyclohexanonemonooxygenase,
there is some indirect evidence derived from kinetic studies that the
initially formed NADP remains bound during the substrate oxygen-
ation process. In fact, release of NADP from the reoxidized enzyme is
the last step to complete the catalytic cycle and is the rate-determining
step in catalysis (22). Cyclohexanone monooxygenase does, however,
not act on aromatic compounds and lacks the N-terminal domain of
HAPMO. A similar kinetic mechanism has been proposed for pig liver
flavin-containing monooxygenase (23), suggesting that continued asso-
ciation of coenzyme is a recurrent theme for this class of monooxygen-
ases, regulating enzyme activity. It has also been found for these
monooxygenases that when no suitable substrate is present, the flavin
C4a-peroxide will slowly decay to form hydrogen peroxide while releas-
ingNADP (Fig. 1), thereby acting as anNADPHoxidase. The observed
oxidase activity of HAPMO in the absence of an aromatic substrate is
0.1 s1 (13), which may suggest that also with HAPMO, NADP
remains bound throughout the oxidative half-reaction. Kamerbeek et al.
(21) do not address the issue of protein-coenzyme complexes present
during the catalytic cycle. The suggested interaction may also be bene-
ficial for the enzyme from a structural point of view.
In this study, we aimed to gain mechanistic insight in HAPMO. For
this, we selected wild type HAPMO and two HAPMOmutants (R339A
and R440A). We used electrospray ionization mass spectrometry and
size-exclusion chromatography as the principal tools to monitor coen-
zyme binding to HAPMO and its effect on protein stability. The major
advantage of mass spectrometry is that it allows the direct observation
of the noncovalent interactions between protein and ligand in real time
even when a stoichiometric heterogeneous mixture is formed (24–26).
The data in this report have provided the first direct evidence that the
nicotinamide coenzyme, either in its reduced or in its oxidized form,
interacts with HAPMO throughout the catalytic cycle and stabilizes the
enzyme to a great extent.
EXPERIMENTAL PROCEDURES
Chemicals, Protein Expression, and Purification—NADPH, NADP,
and 3-aminopyridine adenine dinucleotide phosphate (AADP) were
obtained from Sigma. The hapE gene from P. fluorescensACB encoding
HAPMOwas expressed in Escherichia coli strain TOP10 containing the
vector pBADNK/hapE. The two genes encoding the mutant proteins
R339A and R440A were generated as recently described (21). For effi-
cient expression, E. coli cells were grown at 20 °C with 0.002% (w/v)
arabinose and 50 g/ml ampicillin, essentially as described before (21).
Purification of wild type HAPMO and the R339A and R440A variants
was performed as reported earlier (13).
Nanoflow Electrospray IonizationMass Spectrometry—Enzyme sam-
ples for nanoflow electrospray ionization mass spectrometry experi-
ments were prepared in aqueous 50 mM ammonium acetate, pH 6.8.
Wild type, R339A, and R440A HAPMO were introduced into a nano-
flow electrospray ionization orthogonal time-of-flight mass spectrom-
eter (Micromass LCT,Waters,Manchester, UK)modified for highmass
operation and operating in positive ion mode. For wild type HAPMO
and variants, mass determinations were performed under conditions of
increased pressure in the source and intermediate pressure regions in
themass spectrometer (Pirani gauge 7milibars and Penning gauge 1.2
106 milibars) (27, 28). Nanoflow electrospray voltages were optimized
for transmission of largermultimer protein assemblies (capillary voltage
1450–1650 V and cone voltage 100–125 V). For the mass determina-
tions of NADPH, NADP and AADP electrospray voltages were opti-
mized for transmission of smaller organic molecules (capillary voltage
1050–1150 V and cone voltage 30 V). Borosilicate glass capillaries
(Kwik-Fil,World Precision Instruments Inc., Sarasota, FL) were used on
a P-97 puller (Sutter Instrument Co., Novato, CA) to prepare the nano-
flow electrospray capillaries with an orifice of about 5m. The capillar-
ies were subsequently coatedwith a thin gold layer (500Å) by using an
Edwards ScanCoat Six Pirani 501 sputter coater (Edwards High Vac-
uum International, Crawley, UK). For the kinetic experiments with
NADPH, an automated chip-based electrospray source (Nanomate,
Advion) was used. The automated source was programmed to aspirate
4 l of sample into the conductive pipette tip and then to deliver the
sample to the inlet side of the electrospray chip. This chip consists of
10  10 nozzles in a silicon wafer and a channel extending from the
nozzle to an inlet side at the opposite face of the chip. Electrospray was
initiated by applying an electric voltage of 1850 V, a head pressure of
0.2 p.s.i. to the sample in the pipette tip, and a cone voltage of 30 V.
Analytical Procedures—The enzyme activity of HAPMO was spec-
trophotometrically determined by monitoring the consumption of
NADPH at 340 nm (13) in the absence or presence of 4-hydroxyaceto-
phenone. The consumption ofNADPHand formation ofNADP in the
absence of 4-hydroxyacetophenone was also monitored by mass spec-
trometry. The inhibition constant of NADP with respect to NADPH
was determined spectrophotometrically with varying concentrations of
NADP. The thermal stability of wild type HAPMO and R339A and
R440A variants was analyzed by enzyme inactivation studies and size-
exclusion chromatography. HAPMO (10 M) in 50 mM ammonium
acetate, pH 6.8, was incubated at 36 °C in the absence or presence of
FAD (200M) or AADP (50M). At various time points, aliquots were
taken and analyzed for enzyme activity and hydrodynamical behavior.
Analytical size-exclusion chromatography was performed by using a
Superdex 200 HR 10/30 column (Amersham Biosciences) by using 50
mM ammonium acetate, pH 6.8. Aliquots of 100 l were loaded on the
column and eluted at a flow rate of 0.8 ml/min. Apparent molecular
masses were determined by using a calibration curve made with stand-
ards from amolecular mass marker kit (Bio-Rad) containing thyroglob-
ulin (670 kDa), bovine -globulin (158 kDa), chicken ovalbumin (44
kDa), equine myoglobin (17 kDa), and vitamin B12 (1.35 kDa).
RESULTS
Quaternary Structure of HAPMO Variants—Wild type HAPMO is a
homo-dimeric flavoprotein with each monomer containing a nonco-
valently tightly bound FADcofactor (13). To determine accuratemasses
of wild type, R339A, and R440A HAPMO and to investigate whether
these proteins remain in their native form during ionization, the
FIGURE 1. Proposedmechanism of action of HAPMO. Themechanism is based on the
kinetic analysis of both cyclohexanone monooxygenase (22) and HAPMO. S and P indi-
cate substrate and product, respectively. In the experiments described in this report, no
ketone substrate was present. Under these conditions, the enzyme peroxyflavin inter-
mediate slowly decays to form hydrogen peroxide while releasing NADP acting as an
NADPH oxidase (inner cycle).
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HAPMO variants (1 M) were analyzed by nanoflow electrospray ioni-
zation mass spectrometry in 50 mM ammonium acetate, pH 6.8 (Fig. 2).
As can be seen from Fig. 2A, ionization of wild type HAPMO revealed
two major ion series around 4,500 and 6,000 mass-to-charge (m/z) cor-
responding to molecular masses of 77,610  10 and 145,232  21 Da,
respectively (TABLE ONE). These species represent the monomeric
and dimeric form of HAPMO, with the dimeric species being the dom-
inant form. The molecular masses of the monomeric and dimeric form
are in close agreement with the calculated masses including the FAD
cofactors. Besides the native species containing two FAD molecules,
small amounts of the dimeric apo-protein and dimeric protein with one
FAD molecule were also observed. Thus, the mass spectrometry data
showed the dimeric nature of HAPMO with tight binding of FAD.
Mass determination of R339A and R440A variants revealed molecu-
lar masses of 145,103  43 and 145,092  44 Da, respectively. Again,
these molecular masses are in close agreement with the calculated
masses of the dimers, including two FADmolecules (TABLEONE). The
HAPMO mutants were essentially present as holo-dimers, and only
minor amounts of holo- and apo-monomer and apo-dimer were
observed (Fig. 2, B and C). The mass spectrum of R440A revealed some
more monomeric protein when compared with wild type and R339A
HAPMO, which may indicate that in this particular HAPMO variant,
the interaction between the monomers is somewhat weaker. Interest-
ingly, in the electrospray process, the R339A mutant obtained fewer
charges than wild type and R440A HAPMO. Whereas R339A yielded
for the dimeric form a series of 21 to 25 ions for the dimeric form,
both wild type and R440A yielded series of 23 to 27 ions. The obser-
vation that R339A obtains one charge less per monomer may indicate
that the side chain of Arg-339 is exposed to solvent and is protonated in
wild type enzyme, or alternatively, it may reflect that the mutation
causes a small conformational difference.
Complex Formation between Oxidized HAPMO Variants and
NADP or AADP—In the following, we aimed to monitor noncova-
lent HAPMO variant-nicotinamide coenzyme complexes present dur-
ing the catalytic cycle. To study these protein-ligand interactions by
mass spectrometry, we usedNADP and the coenzyme analogAADP.
For these studies, we could not use NADPH as the reduced coenzyme
would slowly react with oxidized HAPMO. AADP is a nonreducing
coenzyme analog in which the amide function of the nicotinamidemoi-
ety is replaced by a primary amine function. This compound has often
been used to probe coenzyme binding (29–31).
Mixing the wild type enzyme (1 M) with NADP (10 M) and sub-
sequent analysis by nanoflow electrospray ionization mass spectrome-
try did not reveal the presence of a complex between protein and
NADP. Only at a 5-fold higher concentration of coenzyme was some
NADP binding observed ( 5% saturation/monomer). Weak binding
ofNADP to the oxidized enzymewas supported byUV-visible absorb-
ance difference spectroscopy. The addition of 1.5 mMNADP to 10M
HAPMOdid not influence the absorption properties of the flavin cofac-
tor, indicating that NADP does not bind, or at least not in the vicinity
of the isoalloxazine ring.
AADP is known to bind tightly to wild type HAPMO and R440A
with dissociation constants of 0.4 and 0.1 M, respectively (21, 32).
When we mixed wild type HAPMO (1 M) with AADP (1 M), we
observed two new ion series in the mass spectrum (Fig. 3A). Deconvo-
lution of these two ion series revealed molecular masses of 145,773 and
146,493 Da, strongly indicating the presence of dimeric protein in com-
plex with one and two molecules of AADP. Similarly, the mass spec-
trum of a mixture between R440A and AADP revealed complexes
between protein and one and two molecules of AADP (Fig. 3B). The
spectra clearly show that in an equimolar ratio, R440A was nearly satu-
rated with AADP, whereas wild type enzyme was saturated for about
30% with this coenzyme analog. Wild type HAPMO became fully satu-
rated with AADP when the enzyme (1 M) was mixed with a 4-fold
excess of AADP (4 M) (data not shown). The mass spectra also indi-
cated that AADP stabilizes the quaternary structure of wild type and
R440A HAPMO as no apo-protein was observed when the coenzyme
analog was bound. The R339A mutant, on the other hand, did not dis-
play significant binding of AADP (Fig. 3C). Even at a 10-fold excess of
the compound, hardly any protein-AADP complex was formed (Fig.
3D). These results agreed well with earlier studies, which indicate that
R339A only weakly interacts with AADP. In summary, none of the
oxidized HAPMO variants were able to bind specifically to NADP,
whereas wild type and R440A HAPMO, but not R339A, interacted
strongly with the coenzyme analog AADP.
Complex Formation during NADPH Oxidation—The interaction
between NADP and reduced HAPMO has not yet been analyzed
because of the difficulties of directly observing these complexes. Elec-
trospray ionizationmass spectrometry is an ideal directmethod to char-
FIGURE 2.Nanoflow electrospraymass spectra of HAPMOvariants. Enzyme (1M) in
50 mM ammonium acetate, pH 6.8, was infused into the electrospray source. Spectra
were collected in positive ion mode. A, wild type HAPMO; B, R440A HAPMO; C, R339A
HAPMO., apo-monomer; Œ, one molecule of FAD.
TABLE ONE
Molecular masses deduced from the nanoflow electrospraymass
spectra of each dimeric HAPMO variant in complex with FAD
Enzyme Species Cofactor AverageMr Calculated mass a
Da Da
Wild type Dimer FAD 145,232 21 145,222
R339A Dimer FAD 145,103 43 145,052
R440A Dimer FAD 145,092 44 145,052
a Mass calculated on the basis of the primary sequence including the FAD cofactor.
Coenzyme Binding of 4-HydroxyacetophenoneMonooxygenase
SEPTEMBER 16, 2005•VOLUME 280•NUMBER 37 JOURNAL OF BIOLOGICAL CHEMISTRY 32117
acterize such interactions; however, it is difficult to preserve anaerobic
conditions within the source of the electrospray ionization probe.
Therefore, we monitored the binding of the nicotinamide coenzyme to
the enzyme under aerobic conditions in the absence of ketone substrate.
By measuring the redox state of the flavin cofactor during enzyme
turnover, information can be obtained about the rate-limiting step in
catalysis. These experiments have shown that under aerobic conditions
and in the presence of sufficient NADPH, but in the absence of a ketone
substrate, the flavin is mainly in a reduced form in both wild type and
R440A HAPMO (100 and 97%, respectively), whereas in the R339A,
most of the FAD is in the oxidized form. These results indicated that, at
least in the wild type enzyme and R440A variant, flavin reduction is
relatively fast (21). As a consequence, the predominant enzyme form
present during the reaction of substrate-free HAPMO with NADPH
under aerobic conditions may be a complex of a reduced or oxygenated
enzyme species and NADP (Fig. 1, right part of the cycle). This bio-
chemical property allowed us to directly monitor the interaction
between NADP and substrate-free reduced wild type and R440A
HAPMO during turnover by mass spectrometry.
In a typical experiment, wemixed 1MHAPMOenzymewith excess
NADPHandmeasured noncovalent protein complex formation and the
amounts of NADPH and NADP in real time up to 50 min at room
temperature. First, wemonitored themass spectra ofwild typeHAPMO
and R440A variant during incubation with 10MNADPH (Fig. 4, B and
C). Upon mixing with NADPH, the mass spectrum revealed two new
ion series, which corresponds with the binding of one and two mole-
cules of the pyridine nucleotide to the dimeric species of wild type and
R440A variants. Full saturation of the wild type enzyme and R440A
variant with NADP(H) was not reached due to the relatively low con-
centration of NADPH used. Increasing the molar excess may, however,
induce nonspecific complex formation. As the enzyme-bound flavin is
mainly in the reduced or oxygenated state during steady-state condi-
tions, the species we observed in the mass spectrum most probably
reflected the reduced enzyme in complex with NADP. Unfortunately,
the high molecular mass of the HAPMO dimer did not allow us to
differentiate between reduced, oxygenated, or oxidized HAPMO. For
R339A, we did not observe any interaction between the protein and the
nicotinamide coenzyme.
Second, we analyzed the amounts of NADP and NADPH present
during the HAPMO-mediated NADPH oxidase reaction. It should be
noted here that by electrospray ionization mass spectrometry, NADP
is detected as the M ion (744 atomic mass units) as it has a fixed
positive charge in the nicotinamide ring, whereasNADPH is detected as
the [M  H] ion (746 atomic mass units) (33, 34). It was found that
under the experimental conditions used, a freshly prepared solution of
NADPH contained about 8% of NADP. However, no significant spon-
taneous further oxidation occurred within the time frame of the exper-
iment. The enzyme-mediated oxidation of NADPH toNADPwas evi-
denced by the fact that we observed an increase in the amount of
NADP (744 atomic mass units) in time and a decrease in the amount
NADPH (746 atomic mass units) (Fig. 5). Under the experimental con-
ditions applied, wild type HAPMO oxidized about 70% of the added
amount of NADPH within 50 min. The fact that the reaction did not
reach completion can be attributed to product inhibition by NADP.
The R440A mutant did not oxidize NADPH.
To validate the mass spectrometry data and to obtain some informa-
tion about the binding site ofNADP during turnover, wemeasured the
FIGURE 3. Nanoflow electrospray mass spectra of HAPMO variants in the presence
of AADP. Enzyme (1M) in 50mM ammonium acetate, pH 6.8, wasmixedwith AADP
and infused in the electrospray source. Spectra were collected in positive ion mode. A,
wild type enzyme mixed with a stoichiometric amount of AADP; B, R440A HAPMO
mixed with a stoichiometric amount of AADP; C, R339A HAPMO mixed with a stoichi-
ometric amount of AADP; D, R339A HAPMO mixed with a 10-fold molar excess of
AADP. ▫, apo-monomer; Œ, one molecule of FAD;, one molecule of AADP.
FIGURE 4.Nanoflow electrospraymass spectra of HAPMOvariants during turnover
of NADPH. Enzyme (1M) in 50mM ammonium acetate, pH 6.8, wasmixedwith NADPH
(10M), and aliquots were taken at different time points. Mass spectra were recorded in
positive ionmode. A, wild type HAPMO in the absence of NADPH; B, wild type HAPMO in
complex with NADP after 10 min; C, R440A HAPMO in complex with NADP after 10
min. ▫, apo-monomer; Œ, one molecule of FAD; E, one molecule of NADP.
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inhibition behavior of NADP with respect to NADPH. For wild type
enzyme, it was found that NADP behaves as a weak competitive inhib-
itor with a Ki of 390 M. The relatively large difference in Km for
NADPH (12 M) (21) and Ki for NADP indicates that the oxidized
enzyme is efficient in discriminating between the two states of the coen-
zyme. Furthermore, the fact that NADP competes with NADPH for
binding is in line with the kineticmechanisms that have been elucidated
for sequence related monooxygenases (22). If a similar mechanism
would be operative for HAPMO, NADP would dissociate from reoxi-
dized enzyme while being tightly bound to the reduced enzyme.
In summary, the results clearly showed that NADP forms a stable
intermediate complex with reduced and/or oxygenated enzyme but not
with oxidized enzyme. Moreover, we demonstrated that the coenzyme,
either in the reduced or in the oxidized form, is continuously associated
with HAPMO.
Coenzyme Binding Increases the Stability of HAPMO—The observed
interaction of the nicotinamide coenzyme with HAPMO during the
entire reaction cycle might also be of importance for the enzyme from a
structural point of view. Therefore, we probed the thermal stability of
HAPMO variants in the absence or presence of pyridine nucleotide
derivatives. When the free wild type enzyme (10 M) was incubated at
36 °C, we observed a rapid loss of enzyme activity, which coincided with
loss of dimeric structure. After a 120-min incubation at 36 °C, wild type
HAPMO was completely inactivated. By size-exclusion chromatogra-
phy of the same incubations, we observed a loss of quaternary structure
(Fig. 6A), which accompanied enzyme inactivation. The size-exclusion
chromatography data also showed that during the inactivation process,
protein aggregates are formed and that the FAD cofactor is released
(Fig. 6B). We have to mention here that it is very likely that most of the
aggregates formed were too large and/or heterogeneous to be detected
by size-exclusion chromatography. The binding of AADP to HAPMO
appeared to have a dramatic effect on the denaturation process. The
addition of the coenzyme analog clearly stabilized the dimeric holo-
enzyme as evidenced by size-exclusion chromatography analysis (Fig.
6A). In the presence of an excess of free FAD, the aggregation process of
wild type HAPMO was slowed down to some extent, suggesting that
release of the cofactor plays a role in the inactivation process (Fig. 6A).
However, the effect was far less dramatic when compared with AADP.
To probe whether the stabilizing effect of AADP can be related to
ligand binding, the same experiments were performed with the
HAPMO mutants. Again, a similar stabilizing effect of AADP was
found for the R440A variant (data not shown). In line with earlier obser-
vations in this report that R339A interacts onlyweaklywithAADP, the
addition of AADP had no effect on the stability of R339A. Thus, these
results confirmed that the HAPMO structure is stabilized by AADP
binding and that the continued association of the nicotinamide coen-
zyme enhances enzyme stability.
DISCUSSION
In this study, we have reported the first direct analysis of the nonco-
valent interactions of a flavin-containing Baeyer-Villiger monooxygen-
ase with its nicotinamide coenzyme during the enzyme catalytic cycle.
This was accomplished by the application of nanoflow electrospray ion-
ization mass spectrometry. In addition, we studied the effect of coen-
zyme binding on the thermal stability of the enzyme by size-exclusion
chromatography.
Complex Formation between HAPMO and Pyridine Nucleotides—
For these studies, we focused on three HAPMO variants with different
biochemical properties. Wild type HAPMO and R440A interacted
strongly with NADPH, but only wild type enzyme was fully active, and
R339A interacted weakly with NADPH but could still perform catalysis
FIGURE 5.NADPHoxidation byHAPMOvariants asmonitored by nanoflow electro-
spray mass spectrometry. Enzyme (1 M) was mixed with NADPH (100 M) in 50 mM
ammonium acetate buffer, pH 6.8, at room temperature, and mass spectra were
recorded in real time in positive ion mode. A freshly prepared solution of NADPH con-
tained about 8% of NADP. A, oxidation of NADPH (746 atomic mass units) into NADP
(744atomicmassunits) bywild typeHAPMOafter 0 and50minof incubation;B, progress
curve of NADPH oxidation of wild type HAPMO ()and R440A HAPMO (Œ).
FIGURE 6. Stability ofwild typeHAPMOasmonitoredby size-exclusion chromatog-
raphy. Enzyme (10M)was incubated at 36 °C in 50mM ammonium acetate, pH 6.8, and
aliquots were taken at regular time intervals up to 120min. Subsequently, samples were
analyzed with a Superdex 200 HR 10/30 column. A, time-dependent decay of HAPMO
dimers., free enzyme;f, in thepresenceof FAD (200M);, in thepresenceofAADP
(50 M). B, elution pattern of HAPMO incubated for 120 min in the absence (——) or
presence () of AADP. The absorption was monitored at 280 and 440 nm. Free FAD,
HAPMO dimer, and HAPMO aggregates eluted around 18, 11.5, and 7 min, respectively.
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at high coenzyme concentrations. Electrospray ionization mass spec-
trometry data under native conditions showed that the three HAPMO
variants have a dimeric quaternary structure and bind up to two mole-
cules of FAD/dimer. Our data provided strong evidence that the qua-
ternary structures of these three enzyme variants are similar. The
R339A variant had a slightly different mass spectrum with one charge
less per monomer than the two other HAPMO variants. These differ-
ences in charge either reflected small conformational differences
between the enzyme variants orwere directly related to the replacement
of Arg-339 into Ala, thereby removing one potential protonation site
during the electrospray process (4, 35).
Very recently, the crystal structure of phenylacetone monooxygen-
ase, a BVMO from the thermophilic bacterium T. fusca, has become
available (20). This enzyme has 30% sequence identity with HAPMO
and is expected to be homologous from a structural point of view. Phe-
nylacetone monooxygenase exhibits a two-domain architecture resem-
bling that of disulfide oxidoreductases (36). Both the FAD-binding
domain and the NADPH-binding domain exhibit the typical dinucle-
otide-binding fold (37). Unfortunately, no crystallographic model for
the enzyme in complex with a pyridine nucleotide is available. On the
basis of the crystallographic model of phenylacetone monooxygenase, a
structural model of HAPMO was constructed. In this model, residue
Arg-339 in HAPMO aligned with residue Arg-217 in phenylacetone
monooxygenase, which has been assigned as a residue for interacting
with the adenine part of NADPH. This nicely agreed with the observed
effects on coenzyme recognition when this residue is replaced in
HAPMO. It also indicated that Arg-339 in HAPMO is not involved in
monomer-monomer subunit interaction. The published crystallo-
graphic model of the related BVMO (20) also suggests that Arg-339 in
wild type HAPMO is positioned at the surface of the protein and may
well be protonated in the electrospray process. The Arg-440 residue of
HAPMO can also be pinpointed in the phenylacetone monooxygenase
structure and corresponded with Arg-337 in this monooxygenase. It is
located in the active site and is of crucial importance for catalysis as
evidenced by the inability of the HAPMO R440A variant to perform
Baeyer-Villiger reactions. This agreed with the fact that the R440A var-
iant is still able to bind the coenzyme, whereas it is unable to complete
the catalytic cycle. The suggested location ofArg-440 inHAPMOwould
also agreewith the observation that the replacement of this residue does
not result in a decrease of the number of charges during the electrospray
process.
TheMichaelis-Menten constant of NADPH for wild type HAPMO is
relatively low (Km 12 M), suggesting that NADPH interacts strongly
with the oxidized enzyme. Our mass spectrometry experiments with
wild type enzyme and R339A and R440A variants showed that NADP
does not tightly interact with the oxidized enzyme, indicating that
HAPMO can differentiate between oxidized and reduced pyridine
nucleotides. These data were validated by biochemical inhibition stud-
ies, which revealed an inhibition constant of 390M forNADP forwild
type HAPMO. Our studies also revealed tight binding of the coenzyme
analog AADP to wild type and R440A HAPMO but not to R339A.
Apparently, the enzyme has evolved a very specific recognition site for
binding reduced coenzyme to favor catalysis.
HAPMO catalyzes the conversion of ketones into their correspond-
ing esters or lactones by using NADPH as external electron donor (Fig.
1). In the absence of a suitable ketone, substrate consumption of
NADPH by HAPMO results in forming and stabilizing a peroxy-en-
zyme intermediate containing a boundNADPmolecule (13). The con-
sumption of NADPH in the absence of aromatic substrate is slow (kcat
 0.10 s1) and relates to the slow decay of the peroxy-enzyme inter-
mediate yielding hydrogen peroxide as product. These results were con-
firmed by enzyme-monitored turnover experiments, revealing that dur-
ing catalysis, the flavin cofactor in wild type enzyme is mainly in the
reduced and/or oxygenated state (21), awaiting the binding of a suitable
substrate. It has been postulated for sequence-related monooxygenases
that NADP remains bound to the enzyme until the peroxy-enzyme
intermediate has been converted (22, 38).
To characterize the noncovalent interactions of the nicotinamide
coenzyme to HAPMO during turnover, we followed the reaction of
HAPMO variants with NADPH under aerobic conditions in real time
by mass spectrometry. The mass spectra clearly evidenced that
HAPMO, when functioning as an NADPH oxidase (Fig. 1, inner cycle),
is in complex with its coenzyme throughout the catalytic cycle. This
strongly suggested that we observed the binding ofNADP to a reduced
or oxygenated enzyme. This was the first direct evidence that during
catalysis, a BVMO is virtually continuously occupied by the reduced or
oxidized coenzyme, and only during the exchange of NADP with
NADPH is the enzyme in the free form.
Stability of HAPMO—The coenzyme analog AADP was used to
probe the influence of pyridine nucleotides on the stability of HAPMO.
Data from size-exclusion chromatography showed that this analog pre-
vents to a great extent aggregation and inactivation of HAPMOvariants
(wild type and R440A) that are able to bind this coenzyme analog. This
indicated that the effect is not related to the intrinsic properties of the
AADPmolecule as the R339A mutant showed no difference in stabil-
ity upon the addition of the coenzyme analog. The stabilizing effect
suggested that coenzyme binding induces a more rigid tertiary and/or
quaternary structure due to specific noncovalent interactions between
coenzyme and its highly specific binding site. The mass spectrometric
observation that the binding affinity of FAD is enhanced upon the bind-
ing of AADP to wild type HAPMO and R440A may also indicate that
the enzymes adopt a more rigid structure.
In conclusion, this study has established the noncovalent interactions
between pyridine nucleotides and HAPMOduring catalysis. This coen-
zyme binding resulted in a dramatic increase in the stability of the
enzyme. Based on the results of this study, it can be expected that most
of the time, HAPMO will be occupied by coenzyme when it is in its
natural intracellular environment. This indicated that the enzyme is in
vivomore stablewhen comparedwith the isolated enzyme, whichmight
explain the relatively poor stability ofmany reported isolated coenzyme-
dependent enzymes. For example, a well studied homolog of HAPMO,
cyclohexanone monooxygenase, has been shown to inactivate quite
rapidly at room temperature (39). The concept of enzyme stabilization
by AADP binding might be exploited for enzyme purification or stor-
age. The obtained results also showed that the electrospray ionization
technique is well suited to detect noncovalent interactions between
HAPMO subunits and between HAPMO and ligands and to monitor
these interactions in real time (25, 26).
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